World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
19257
World Ranking
1988
National Ranking
974

Medicine

D-Index
75
Citations
19331
World Ranking
19162
National Ranking
9555

David I. Watkins publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David I. Watkins sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 211 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David I. Watkins D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David I. Watkins sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David I. Watkins is affiliated with George Washington University in the United States. Their research spans multiple fields within medicine, immunology, and microbiology, with a significant focus on infectious diseases and immunological responses.

The main fields of study they contribute to include:

  • Medicine
  • Immunology and Microbiology

Within these, they explore specialized subfields such as:

  • Immunology
  • Infectious Diseases
  • Virology
  • Public Health, Environmental and Occupational Health
  • Epidemiology

Their work covers key research topics including:

  • HIV Research and Treatment
  • Mosquito-borne diseases and control
  • Immune Cell Function and Interaction
  • Viral Infections and Vectors
  • T-cell and B-cell Immunology
  • Herpesvirus Infections and Treatments
  • Viral Infections and Outbreaks Research

David I. Watkins's research outputs have appeared in a variety of scientific journals. Frequent publication venues are:

  • arXiv (Cornell University)
  • Journal of Virology
  • Frontiers in Immunology
  • Molecular Therapy - Methods & Clinical Development
  • Proceedings of the National Academy of Sciences

Representative research papers authored or co-authored by David I. Watkins include:

  • "Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine," 2020, Proceedings of the National Academy of Sciences
  • "Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome," 2020, Journal of Virology
  • "Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies," 2020, Molecular Therapy - Methods & Clinical Development
  • "Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naïve and DENV-Exposed Individuals in a Brazilian Cohort," 2022, Frontiers in Immunology
  • "Immunophenotyping of Rhesus CMV-Specific CD8 T-Cell Populations," 2020, Cytometry Part A

David I. Watkins collaborates regularly with a group of researchers, with frequent co-authors including:

  • Michael J. Ricciardi
  • Eva G. Rakasz
  • Núria Pedreño-López
  • Jeffrey D. Lifson
  • Maurício A. Martins

Best Publications

  • Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.

    Todd M. Allen;David H. O'Connor;Peicheng Jing;John L. Dzuris

  • HIV and SIV CTL escape: implications for vaccine design.

    Philip J. R. Goulder;David I. Watkins

  • Impact of MHC class I diversity on immune control of immunodeficiency virus replication

    Philip J. R. Goulder;David I. Watkins

  • Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers

    Ann J. Hessell;Eva G. Rakasz;Pascal Poignard;Pascal Poignard;Lars Hangartner;Lars Hangartner

  • Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

    David T. Evans;David T. Evans;David H. O'Connor;Peicheng Jing;John L. Dzuris

  • Reversion of CTL escape-variant immunodeficiency viruses in vivo.

    Thomas C Friedrich;Elizabeth J Dodds;Levi J Yant;Lara Vojnov

  • Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L

    Ann J. Hessell;Eva G. Rakasz;David M. Tehrani;Michael Huber

  • Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.

    David H. O'Connor;Todd M. Allen;Thorsten U. Vogel;Peicheng Jing

  • The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B*17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication

    Levi J. Yant;Thomas C. Friedrich;Randall C. Johnson;Gemma E. May

  • HIV vaccine research: the way forward.

    Anthony S. Fauci;Margaret I. Johnston;Carl W. Dieffenbach;Dennis R. Burton

  • Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans.

    David I Watkins;Dennis R Burton;Esper G Kallas;John P Moore

  • Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression.

    Jonah B. Sacha;Chungwon Chung;Eva G. Rakasz;Sean P. Spencer

  • Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag

    Danilo R. Casimiro;Fubao Wang;William A. Schleif;Xiaoping Liang

  • Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications

    Huynh Hoa Bui;John Sidney;Bjoern Peters;Muthuraman Sathiamurthy

  • HIV vaccine design: insights from live attenuated SIV vaccines

    Wayne C Koff;Philip R Johnson;David I Watkins;Dennis R Burton

  • Premature Induction of an Immunosuppressive Regulatory T Cell Response during Acute Simian Immunodeficiency Virus Infection

    Jacob D. Estes;Qingsheng Li;Matthew R. Reynolds;Stephen W Wietgrefe

  • Expression of the Major Histocompatibility Complex Class I Molecule Mamu-A*01 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication

    Bianca R. Mothé;Jason Weinfurter;Chenxi Wang;William Rehrauer

  • Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.

    Allen Tm;Sidney J;del Guercio Mf;Glickman Rl

  • Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239

    Nancy A. Wilson;Jason Reed;Gnankang S. Napoe;Shari Piaskowski

  • Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239

    Helen Horton;Thorsten U. Vogel;Donald K. Carter;Kathy Vielhuber

Frequent Co-Authors

David H. O’Connor
David H. O’Connor University of Wisconsin–Madison
Todd M. Allen
Todd M. Allen Harvard University
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
Norman L. Letvin
Norman L. Letvin Beth Israel Deaconess Medical Center
Alessandro Sette
Alessandro Sette La Jolla Institute For Allergy & Immunology
Ronald C. Desrosiers
Ronald C. Desrosiers University of Miami
Thomas C. Friedrich
Thomas C. Friedrich University of Wisconsin–Madison
David B. Allison
David B. Allison Indiana University
John Sidney
John Sidney La Jolla Institute For Allergy & Immunology
Jonah B. Sacha
Jonah B. Sacha Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their career in immunology, exploring related nursing degrees can open up diverse opportunities in healthcare. Many professionals start by earning an accelerated BSN, which helps non-nurses quickly gain the foundational skills needed in clinical settings. Programs like accelerated bsn programs for non nurses are designed to make this transition as smooth as possible.

Once foundational nursing skills are gained, specialized roles such as a Family Nurse Practitioner (FNP) become viable. Those with a background in immunology might consider accelerated fnp online programs to expedite their path to advanced practice nursing.

For non-nurses looking to enter the field, online rn programs for non nurses offer flexible study options that accommodate working professionals and help bridge the gap between different healthcare roles.

Additionally, certification in specialized areas is crucial for career growth. Transitioning to roles like acute care nurse practitioner demands specific credentials, including the acute care nurse practitioner certification. This further enhances a nurse’s ability to care for complex patient populations, a valuable skill set in immunology-related healthcare environments.

Best Scientists Citing David I. Watkins

Trending Scientists

Recently Published Articles